Phase 3 Clinical Trial of CartiLife® in Korea
NCT05051332
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
104
Enrollment
INDUSTRY
Sponsor class
Conditions
Articular Cartilage Defect
Articular Cartilage Degeneration
Interventions
DRUG:
Autologous Chondrocyte Implantation (CartiLife®)
PROCEDURE:
Microfracture Surgery
Sponsor
Biosolution Co., Ltd.